Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.

Irish biopharmaceutical company Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic hypersomnia (IH). The double-blind, ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...

The Canadian Red Cross is offering personalized recovery support to people impacted by the flooding and extreme weather event in British Columbia that took place on November 14, 2021. The Red Cross ...

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025ORX750 Phase 2a ...

Researchers from the University of California, San Francisco discovered that individuals who experience increasing daytime sleepiness or take "excessive" naps may have double the risk of ...

Officials announced two days of street parking restrictions on a block in downtown Hanover, beginning Monday. According to a release by the Hanover Borough Police Department, a temporary no ...

A Westerly police officer is under investigation for an allegation of using excessive force during an arrest earlier this month, the NBC10 I-Team has learned. The matter has been referred the ...

Deputy Minister of Shipping Marina Hadjimanolis attended the European Shipping Summit (ESS) this week, where she underlined the need to enhance competitiveness and inclusivity within European ...

The lipid remodeling that occurs under low P conditions, which shifts from phospholipid-based to non-phospholipid-based lipids, could similarly support membrane stability in high-salinity environments ...

WASHINGTON (TNND) — Government watchdog group Open the Books reviewed all the federal agencies and mapped their increased spending over 24 years, finding some agencies grew as much as 500%.